Summit Therapeutics established a clinical trial collaboration with Pfizer to develop ivonescimab for NSCLC and solid tumors.

An October 2024 study previously found that toxic flame retardants had been discovered in 85% of the screened consumer ...

Your Health MattersMeritus Health Early onset colon cancer is a growing problem, especially for age groups that historically ...

A new research paper was published in Oncotarget, Volume 16, on February 18, 2025, titled “Robust p53 phenotypes and ...

A unique protein designed by Cedars-Sinai Cancer investigators can cross the protective blood–brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows.

A new research paper was published in , Volume 16, on February 18, 2025, titled "Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells." ...

A 25-year-old woman from the Poyntzpass area has said life has become a "complete whirlwind" after a trip to Turkey for a ...

Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative ...

Dr Grace Adjoa Ocansey, a Clinical Epidemiologist, has suggested that the National Health Insurance Scheme (NHIS) should be ...

Former Independent Electoral and Boundaries Commission (IEBC) chairperson Wafula Chebukati battled brain cancer until he died ...

Former Independent Electoral and Boundaries Commission (IEBC) chairperson Wafula Chebukati had a cancerous brain tumor that was recurrent.

According to studies, eating the fruit once every day is enough to protect your DNA by 60% - reducing your risk of chronic ...